Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Dell Laser Consultants is First to Introduce Revolutionary ZEISS SMILE PRO Procedure in Austin
Healthcare & PharmaceuticalCompany Update

Dell Laser Consultants is First to Introduce Revolutionary ZEISS SMILE PRO Procedure in Austin

August 13, 2024 10:13 AM

AUSTIN, TX / ACCESSWIRE / August 13, 2024 / Dell Laser Consultants, the premier eye care provider in Austin, announces it is the first practice in the area to offer ZEISS SMILE Pro (Small Incision Lenticule Extraction), a groundbreaking laser vision correction procedure. Dell Laser Consultants ZEISS SMILE Pro ZEISS SMILE Pro, developed by ZEISS, is a minimally invasive procedure that corrects nearsightedness and astigmatism. Using the advanced...

Read more
Hedden & Gunn Plastic Surgery Welcomes New Facial Plastic Surgeon, Dr. Beau Vandiver
Healthcare & PharmaceuticalCompany Update

Hedden & Gunn Plastic Surgery Welcomes New Facial Plastic Surgeon, Dr. Beau Vandiver

August 13, 2024 10:00 AM

BIRMINGHAM, AL / ACCESSWIRE / August 13, 2024 / Hedden & Gunn Plastic Surgery, a distinguished member of Ascend Aesthetic Partners, announces the appointment of Dr. Beau Vandiver as its newest facial plastic surgeon, effective July 31, 2024. Dr. Vandiver joins the esteemed practice bringing a wealth of expertise and a dedication to advancing patient care in the Birmingham, Alabama area.Hedden & Gunn Plastic Surgery Logo Dr. Vandiver obtained his...

Read more
Leapcure Acquires Honeybee Trials: Expanding Patient Engagement and Research Site Solutions for Clinical Trials
Healthcare & PharmaceuticalMergers and Acquisitions

Leapcure Acquires Honeybee Trials: Expanding Patient Engagement and Research Site Solutions for Clinical Trials

August 13, 2024 10:00 AM

Leapcure enhances clinical trials and affordable patient recruitment with strategic acquisition of Honeybee Trials.REDWOOD CITY, CA / ACCESSWIRE / August 13, 2024 / Leapcure, a global leader and pioneer in improving clinical trial accessibility and empathy, is proud to announce the acquisition of Honeybee Trials, a company renowned for its extensive clinical trial product capabilities and successful collaborations with leading institutional...

Read more
Digipath Name and Symbol Change Approved, Company Begins Trading as Hypha Labs, Inc. (FUNI)
Healthcare & PharmaceuticalCompany Name Change

Digipath Name and Symbol Change Approved, Company Begins Trading as Hypha Labs, Inc. (FUNI)

August 13, 2024 9:15 AM

Hypha Labs, Inc. formerly (OTC PINK:DIGP), has been approved to commence trading as Hypha Labs, Inc. (OTC PINK:FUNI) on August 13, 2024. Hypha Labs has developed the first in-home mushroom accelerator to allow for the production of high quality mushroom ingredients in just eight days."We are pleased to at last align our corporate name and ticker with our pioneering operations in the development of a suite of functional mushroom ingredient...

Read more
Lenstec Appoints Jimmy Chacko as Chief Operating Officer
Healthcare & PharmaceuticalCompany Update

Lenstec Appoints Jimmy Chacko as Chief Operating Officer

August 13, 2024 9:13 AM

ST. PETERSBURG, FL / ACCESSWIRE / August 13, 2024 / Lenstec Inc., a leading innovator in intraocular lens (IOL) technology, today announced the appointment of Jimmy Chacko as Chief Operating Officer (COO), effective immediately. As the next generation of leadership, Chacko will oversee daily business operations, develop growth strategies, and ensure optimal resource allocation across departments. With over two decades at Lenstec, Chacko joined...

Read more
Xcelerate, Inc. Releases Shareholder Update
Healthcare & PharmaceuticalCompany Update

Xcelerate, Inc. Releases Shareholder Update

August 13, 2024 9:05 AM

Xcelerate, Inc.'s (OTCQB:XCRT) CEO, Mike O'Shea, today released this letter and shareholder update.Dear Shareholder,On April 29, 2024, we announced that we had filed our annual report on Form 1-K with the SEC. This report included our annual independent financial audit for the years ended 2022 and 2023. Our intent was to then file our amended registration statement on Form S-1/A with the SEC in order to continue our fundraising and uplisting...

Read more
Inc. Names 1upHealth No. 95 on the 2024 Inc. 5000
Healthcare & PharmaceuticalAwards

Inc. Names 1upHealth No. 95 on the 2024 Inc. 5000

August 13, 2024 9:03 AM

Today, Inc. announced today that 1upHealth, the leading FHIR® platform provider for claims and clinical data interoperability, ranked No. 95 on the 2024 Inc. 5000, the annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful companies within the economy's most dynamic segment-its independent, entrepreneurial businesses. Microsoft, Meta, Chobani, Under Armour,...

Read more
U.S. News & World Report Ranks John Theurer Cancer Center as the #1 Cancer Program in NJ and the Only Top 50 Cancer Program in the State
Healthcare & PharmaceuticalCompany Update

U.S. News & World Report Ranks John Theurer Cancer Center as the #1 Cancer Program in NJ and the Only Top 50 Cancer Program in the State

August 13, 2024 9:00 AM

Regional Cancer Care Associates is pleased to announce the recognition of John Theurer Cancer Center as the #1 Cancer Program in New Jersey by U.S. News and World ReportTEANECK, NJ / ACCESSWIRE / August 13, 2024 / Among over 1,500 cancer programs accredited nationwide, JTCC was ranked among the Top 50 and is the only one in the state of New Jersey. We are honored by this recognition, which is a testimony to the expertise, dedication, and...

Read more
Affordable Prescription Solutions by CostPill
Healthcare & PharmaceuticalCompany Update

Affordable Prescription Solutions by CostPill

August 13, 2024 9:00 AM

0% Markup on Generics, Best Prices for Brand and OTC MedicationsNEWARK, CA / ACCESSWIRE / August 13, 2024 / CostPill, a pioneering service from TIB Pharmacy Inc., proudly announces its official launch, offering a transformative approach to accessing affordable prescription medications. With a mission rooted in transparency and public health enhancement, CostPill is set to redefine the pharmaceutical landscape by providing cost-effective,...

Read more
DentalXChange Announces the Launch of PayerXChange, Empowering Dental Insurance Payers to Collaborate and Enhance Communication With Their Provider Network
Healthcare & PharmaceuticalProduct Announcements

DentalXChange Announces the Launch of PayerXChange, Empowering Dental Insurance Payers to Collaborate and Enhance Communication With Their Provider Network

August 13, 2024 9:00 AM

IRVINE, CA / ACCESSWIRE / August 13, 2024 / DentalXChange announces the launch of PayerXChange, a secure online portal platform driving administration efficiency and expense saving across payers, providers, and patients. This time-saving solution empowers dental insurance payers to elevate transparency and collaboration within their provider network. "We are excited to partner with payers to drive transparency to required patient benefits...

Read more
MD Clarity Included on Inc. 5000’s List of Fastest-Growing Private Companies in America
Healthcare & PharmaceuticalCompany Update

MD Clarity Included on Inc. 5000’s List of Fastest-Growing Private Companies in America

August 13, 2024 9:00 AM

SEATTLE, WA / ACCESSWIRE / August 13, 2024 / MD Clarity, a leading provider of provider revenue optimization software, today announced its placement on the Inc. 5000 list of the fastest-growing private companies in America. This recognition highlights MD Clarity's rapid growth and commitment to transforming the healthcare revenue cycle. Logo MD Clarity Logo The Inc. 5000 list represents a comprehensive overview of the most innovative and...

Read more
Hop On A Cure Announces Grant for Duke University ALS Clinic Study on Efficacy of BL-001 in People With ALS
Healthcare & PharmaceuticalAwards

Hop On A Cure Announces Grant for Duke University ALS Clinic Study on Efficacy of BL-001 in People With ALS

August 13, 2024 9:00 AM

Duke University's Dr. Richard Bedlack to Receive Hop On A Cure Inaugural Accelerate A Miracle Project Award for Research ExcellenceATLANTA, GA / ACCESSWIRE / August 13, 2024 / Hop On A Cure, a leading advocate in the fight against ALS, announced today their grant placement with Duke University's pilot trial to investigate the safety, tolerability, and preliminary efficacy of BL-001 probiotic in people with ALS. Having found a direct connection...

Read more
From Pharmacist to International Food Markets, Javid Javdani Shares His Tips for Success
Healthcare & PharmaceuticalCompany Update

From Pharmacist to International Food Markets, Javid Javdani Shares His Tips for Success

August 13, 2024 8:45 AM

Javid Javdani, a distinguished Doctor of Pharmacy and successful entrepreneur based in San Diego, California recently shared his insights in an interview with Infinite Sights. The interview explores Javid's inspiring journey from a young immigrant to a leading figure in the food retail industry.Javid's story is a testament to his dedication to innovation, community service, and excellence. Born in Iran, Javid immigrated to the United States in...

Read more
Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership To Help Address the Growing HIV Crisis in Eastern Europe and Central Asia
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership To Help Address the Growing HIV Crisis in Eastern Europe and Central Asia

August 13, 2024 8:45 AM

Gilead Sciences, Inc. (Nasdaq:GILD) and the Elton John AIDS Foundation (EJAF) announced a five-year extension of the RADIAN ® partnership to help meet the needs of the most vulnerable key populations in Eastern Europe and Central Asia (EECA) where the HIV epidemic is growing. RADIAN will continue supporting the initiatives of trusted, grassroots organizations who are working to address HIV-related challenges in the region.While HIV is declining...

Read more
Phase 1b/2
Healthcare & PharmaceuticalCompany Update

Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated

August 13, 2024 8:05 AM

Aptevo's lead candidate APVO436 (mipletamig) to be evaluated in combination with standard of care venetoclax and azacitidineCompany anticipates new data set to bolster existing compelling data reported to date, including efficacy outcomes more than double the benchmarks*Outcomes also expected to identify recommended Phase 2 doseAPVO436 renamed as mipletamig: Aptevo adopts new generic name for future useSEATTLE, WA / ACCESSWIRE / August 13, 2024...

Read more
Compassion Center Expresses Gratitude to Rebecca Siewert of N.W. Classic and Woodburn Property Management for Highlighting Housing Disparities in Oregon
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Compassion Center Expresses Gratitude to Rebecca Siewert of N.W. Classic and Woodburn Property Management for Highlighting Housing Disparities in Oregon

August 13, 2024 8:00 AM

Compassion Center, headquartered in Hillsboro, Oregon, is a pioneer in integrative healthcare, dedicated to improving global quality of life through individualized treatment plans that blend allopathic, traditional, and alternative modalities. Through the Center for Incubation & Findings Research (CIFR), we address socio-economic challenges like housing instability, food security, and access to mental health and integrative healthcare,...

Read more
Jaguar Health Reports Second Quarter 2024 Financial Results
Healthcare & PharmaceuticalEarnings

Jaguar Health Reports Second Quarter 2024 Financial Results

August 13, 2024 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / August 13, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today reported its consolidated second-quarter 2024 financial results and provided Company updates.The combined net revenue for the Company's crofelemer prescription products, Mytesi® and Canalevia®-CA1, and the Company's non-prescription products, was approximately $2.72 million in the second quarter of 2024, representing an increase...

Read more
Vytalize Health Named Fastest-Growing Private Company in America by Inc. Magazine
Healthcare & PharmaceuticalAwards

Vytalize Health Named Fastest-Growing Private Company in America by Inc. Magazine

August 13, 2024 7:15 AM

Company Ranks No. 1 on the Prestigious Inc. 5000 Across All Industries After Achieving $1.5 Billion in Revenue for 2023 and a Remarkable Three-Year Revenue Growth Rate of 90,778%HOBOKEN, NJ / ACCESSWIRE / August 13, 2024 / Vytalize Health, a leading risk-bearing provider enablement platform, announced it ranked No. 1 on the 2024 Inc. 5000 list of fastest-growing private companies in America. The company achieved the top ranking with a remarkable...

Read more
Phytopathological Disease Diagnostics Market Is Expected to Reach USD 163.4 Million by 2034 And Grow at A CAGR of 4.5% | Future Market Insights, Inc.
Healthcare & PharmaceuticalCompany Update

Phytopathological Disease Diagnostics Market Is Expected to Reach USD 163.4 Million by 2034 And Grow at A CAGR of 4.5% | Future Market Insights, Inc.

August 13, 2024 7:00 AM

The global phytopathological disease diagnostics market is estimated to reach USD 105.2 million in 2024. Projecting forward, the market is expected to reach USD 163.4 million by 2034, reflecting a steady CAGR of 4.5% during the forecast. The industry is primarily driven by the increasing global demand for food security and sustainable agriculture practices. With rising concerns about crop diseases and their impact on yield and quality, there is...

Read more
Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners
Healthcare & PharmaceuticalAwards

Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners

August 13, 2024 7:00 AM

For Fifth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 ScholarshipLAVAL, QC / ACCESSWIRE / August 13, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the recipients of its 2024 Salix Gastrointestinal Health Scholars Program. For the fifth year, Bausch Health is proud to award 10 deserving students living...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?